PureTech Health plc Amends Akili, Inc. Filing

TL;DR

PureTech Health plc updated its Akili, Inc. filing - ownership change incoming.

AI Summary

PureTech Health plc, formerly Social Capital Suvretta Holdings Corp. I, has filed an amendment (No. 2) to its Schedule 13D concerning Akili, Inc. on July 9, 2024. The filing indicates a change in the reporting person's beneficial ownership of Akili, Inc. common stock. The specific details of the change in ownership percentage or number of shares are not provided in this excerpt.

Why It Matters

This filing signals a potential shift in the ownership structure or investment strategy concerning Akili, Inc., which could impact its stock price and corporate governance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and uncertainty for the subject company.

Key Players & Entities

• PureTech Health plc (company) — Reporting Person
• Akili, Inc. (company) — Subject Company
• Social Capital Suvretta Holdings Corp. I (company) — Former Company Name
• Bharatt Chowrira (person) — Contact Person

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d864699dsc13da.htm (SC 13D/A) — 41KB
• 0001193125-24-176581.txt ( ) — 43KB

of the Schedule 13D is hereby supplemented as follows

Item 4 of the Schedule 13D is hereby supplemented as follows: Merger Agreement On May 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the Merger Agreement) with Virtual Therapeutics Corporation, a Delaware corporation (Parent), and Alpha Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Purchaser). In connection with the Issuers execution of the Merger Agreement, on May 29, 2024, PureTech Health LLC (PureTech Health) and certain other beneficial owners of Common Stock entered into Tender and Support Agreements (the Tender and Support Agreements) with Parent and Purchaser. The Tender and Support Agreements provide, among other things, that beneficial owners that are party to the Tender and Support Agreements will tender all of the shares of Common Stock of the Issuer held by them to Purchaser in the Offer, upon the terms and subject to the conditions of the Tender and Support Agreement, and (if applicable) vote all shares of Common Stock in favor of the Merger. By entering into the Tender and Support Agreement, PureTech Health and the other beneficial owners party thereto also agreed to other customary terms and conditions, including certain transfer and voting restrictions, in respect of shares of Common Stock that they beneficially own. On July 2, 2024, the tender offer and merger described above closed. The Reporting Persons sold an aggregate of 12,527,477 shares of Issuer Common Stock in the tender offer, which represented all shares of Issuer Common Stock held by the Reporting Persons. Item5. Interest in the Securities of the Issuer

(a)-(b) of the Schedule 13D are hereby amended and supplemented as follows

Item 5(a)-(b) of the Schedule 13D are hereby amended and supplemented as follows: The information contained on the cover pages of this Amendment is incorporated herein by reference.

(c) of the Schedule 13D is hereby amended and supplemented as follows

Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows: The information contained in Item 4 of this Amendment is incorporated herein by reference.

(e) of the Schedule 13D is hereby amended and supplemented as follows

Item 5(e) of the Schedule 13D is hereby amended and supplemented as follows: As of July 2, 2024, the Reporting Persons ceased to beneficially own more than five percent of the outstanding Issuer Common Stock. 3

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : July 9, 2024 PureTech Health plc By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer PureTech Health LLC By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer 4

View Full Filing

View this SC 13D/A filing on SEC EDGAR